Cargando…

Advanced glycation end‐products are a risk for muscle weakness in Japanese patients with type 1 diabetes

Accumulation of advanced glycation end‐products (AGEs) is thought to contribute to muscle weakness in a diabetic animal model. Skin autofluorescence is a proposed marker for accumulation of AGEs in the skin. We aimed to investigate the relationship between AGEs accumulation, sarcopenia and muscle fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Hiroyasu, Kuroda, Akio, Araki, Michiko, Suzuki, Reiko, Taniguchi, Satoshi, Tamaki, Motoyuki, Akehi, Yuko, Matsuhisa, Munehide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415451/ https://www.ncbi.nlm.nih.gov/pubmed/27727515 http://dx.doi.org/10.1111/jdi.12582

Ejemplares similares

Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
por: Mori, Hiroyasu, et al.
Publicado: (2019)

Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index
por: Mitsui, Yukari, et al.
Publicado: (2021)

New risk factors of severe hypoglycemia
por: Matsuhisa, Munehide, et al.
Publicado: (2018)

Novel method utilizing bisulfite conversion with dual amplification‐refractory mutation system polymerase chain reaction to detect circulating pancreatic β‐cell cfDNA
por: Okada, Asami, et al.
Publicado: (2022)

High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study
por: Mori, Hiroyasu, et al.
Publicado: (2020)

Chronic Intake of a Meal Including Alaska Pollack Protein Increases Skeletal Muscle Mass and Strength in Healthy Older Women: A Double-Blind Randomized Controlled Trial
por: Mori, Hiroyasu, et al.
Publicado: (2022)

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
por: King, Allen B., et al.
Publicado: (2016)

Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile‐onset type 1 diabetes mellitus
por: Masuda, Takafumi, et al.
Publicado: (2022)

Circulating osteocalcin as a bone-derived hormone is inversely correlated with body fat in patients with type 1 diabetes
por: Takashi, Yuichi, et al.
Publicado: (2019)

Characterisation of Ppy-lineage cells clarifies the functional heterogeneity of pancreatic beta cells in mice
por: Fukaishi, Takahiro, et al.
Publicado: (2021)

Involvement of advanced glycation end‐products in ‘hyperglycemic memory’
por: Nishikawa, Takeshi, et al.
Publicado: (2015)

Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm
por: Miyagi, Masahiko, et al.
Publicado: (2018)

Short‐ and long‐term effect of sitagliptin after near normalization of glycemic control with insulin in poorly controlled Japanese type 2 diabetic patients
por: Fujisawa, Keiko, et al.
Publicado: (2013)

Safety of the batteries and power units used in insulin pumps: A pilot cross‐sectional study by the Association for the Study of Innovative Diabetes Treatment in Japan
por: Murata, Takashi, et al.
Publicado: (2017)

Use of iGlarLixi for Management of Type 2 Diabetes in Japanese Clinical Practice: SPARTA Japan, a Retrospective Observational Study
por: Matsuhisa, Munehide, et al.
Publicado: (2022)

Skin Autofluorescence is Associated with Early-stage Atherosclerosis in Patients with Type 1 Diabetes
por: Osawa, Saeko, et al.
Publicado: (2017)

Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study
por: Miyoshi, Hideaki, et al.
Publicado: (2023)

Regular insulin, rather than rapid‐acting insulin, is a suitable choice for premeal bolus insulin in lean patients with type 2 diabetes mellitus
por: Kuroda, Akio, et al.
Publicado: (2013)

Association of advanced glycation end products in Dupuytren disease
por: Takase, Fumiaki, et al.
Publicado: (2018)

Nasal glucagon as a viable alternative for treating insulin‐induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: A phase 3 randomized crossover study
por: Matsuhisa, Munehide, et al.
Publicado: (2020)

A Case of Hypocalcemia with Severe Vitamin D Deficiency following Treatment for Graves' Disease with Methimazole
por: Miyashita, Kazuyuki, et al.
Publicado: (2013)

Advanced glycation end products and cognitive impairment in schizophrenia
por: Kobori, Akiko, et al.
Publicado: (2021)

Fingertip advanced glycation end products and psychotic symptoms among adolescents
por: Miyashita, Mitsuhiro, et al.
Publicado: (2021)

Relationship Between Carotid Intima-Media Thickness and the Presence and Extent of Coronary Stenosis in Type 2 Diabetic Patients With Carotid Atherosclerosis but Without History of Coronary Artery Disease
por: Kasami, Ryuuichi, et al.
Publicado: (2011)

Dehydroepiandrosterone Sulfate, an Adrenal Androgen, Is Inversely Associated with Prevalence of Dynapenia in Male Individuals with Type 2 Diabetes
por: Yasui, Saya, et al.
Publicado: (2023)

The current status of treatment‐related severe hypoglycemia in Japanese patients with diabetes mellitus: A report from the committee on a survey of severe hypoglycemia in the Japan Diabetes Society
por: Namba, Mitsuyoshi, et al.
Publicado: (2018)

Suppression of the Hypothalamic-pituitary-adrenal Axis by Maximum Androgen Blockade in a Patient with Prostate Cancer
por: Kondo, Takeshi, et al.
Publicado: (2016)

Advanced Glycation End-Products in Skeletal Muscle Aging
por: Olson, Lucas C., et al.
Publicado: (2021)

Ethics and practical mitigations for ongoing clinical trials during the COVID-19 pandemic
por: Suzuki, Shota, et al.
Publicado: (2020)

Advanced glycation end-products reduce lipopolysaccharide uptake by macrophages
por: Kitaura, Atsuhiro, et al.
Publicado: (2021)

Association between Japanese Diet Adherence and Muscle Weakness in Japanese Adults Aged ≥50 Years: Findings from the JSTAR Cohort Study
por: Shimizu, Akio, et al.
Publicado: (2023)

Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence
por: Hangai, Mari, et al.
Publicado: (2016)

The effect of guardians' health literacy on the child's spending time at home: A cross-sectional study among Japanese schoolchildren
por: Sato, Yuki, et al.
Publicado: (2023)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Basal Insulin Requirement Is ∼30% of the Total Daily Insulin Dose in Type 1 Diabetic Patients Who Use the Insulin Pump
por: Kuroda, Akio, et al.
Publicado: (2011)

Skin advanced glycation end product accumulation and muscle strength among adult men
por: Momma, Haruki, et al.
Publicado: (2010)

Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population
por: Isami, Fumiyuki, et al.
Publicado: (2018)

Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis
por: Kaneto, Hideaki, et al.
Publicado: (2010)

Association of Japanese and Mediterranean Dietary Patterns with Muscle Weakness in Japanese Community-Dwelling Middle-Aged and Older Adults: Post Hoc Cross-Sectional Analysis
por: Shimizu, Akio, et al.
Publicado: (2022)

Intestinal transepithelial permeability of oxytocin into the blood is dependent on the receptor for advanced glycation end products in mice
por: Higashida, Haruhiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1v8lsh67brvml7b48ic7t453pq